Deficiency Letter Impurity Reference Standards

This category focuses on addressing specific impurities that urgently need to be supplemented due to official review comments (notice of supplement) during the drug registration application (NDA/ANDA) process. These impurities typically involve further inquiries from review agencies regarding the specificity of existing impurity profiles, toxicological data, or analytical methods, and are the "last mile" challenges that must be overcome before a drug can be approved for marketing. We provide various customized impurity reference standards tailored to supplement requirements, covering newly identified degradation products, specific process by-products, potentially mutagenic impurities, and chiral isomers. All products undergo rigorous structural confirmation (NMR, LC-MS/MS, HPLC, etc.), with precise purity and complete data, supporting you in quickly responding to official supplement requirements, supplementing stability studies, toxicological assessments, or methodological verifications. Our products help you efficiently complete the registration application materials, shorten the review cycle, and ensure the smooth approval and marketing of your drug.